Literature DB >> 24112317

Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).

E N Behrend1, H S Kooistra, R Nelson, C E Reusch, J C Scott-Moncrieff.   

Abstract

This report offers a consensus opinion on the diagnosis of spontaneous canine hyperadrenocorticism. The possibility that a patient has hyperadrenocorticism is based on the history and physical examination. Endocrine tests should be performed only when clinical signs consistent with HAC are present. None of the biochemical screening or differentiating tests for hyperadrenocorticism are perfect. Imaging can also play a role. Awareness of hyperadrenocorticism has heightened over time. Thus, case presentation is more subtle. Due to the changes in manifestations as well as test technology the Panel believes that references ranges should be reestablished. The role of cortisol precursors and sex hormones in causing a syndrome of occult hyperadrenocorticism remains unclear.
Copyright © 2013 by the American College of Veterinary Internal Medicine.

Entities:  

Keywords:  Adrenal cortex; Cushing's syndrome; Dog; Pituitary

Mesh:

Substances:

Year:  2013        PMID: 24112317     DOI: 10.1111/jvim.12192

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  54 in total

1.  The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours.

Authors:  Karin Sanders; Koen Cirkel; Guy C M Grinwis; Erik Teske; Sebastiaan A van Nimwegen; Jan A Mol; Jan Willem Hesselink; Hans S Kooistra; Sara Galac
Journal:  Vet Comp Oncol       Date:  2019-04-07       Impact factor: 2.613

Review 2.  Update on the use of trilostane in dogs.

Authors:  Julie Lemetayer; Shauna Blois
Journal:  Can Vet J       Date:  2018-04       Impact factor: 1.008

3.  Effect of EDTA on measurement of cortisol and thyroxine by chemiluminescent enzyme immunoassay in dogs.

Authors:  Dana A Schechter; Hollie P Lee; Robert J Kemppainen; Ellen N Behrend
Journal:  J Vet Diagn Invest       Date:  2020-04-02       Impact factor: 1.279

4.  Cortisol urinary metabolites in dogs with hypercortisolism, congestive heart failure, and healthy dogs: pilot investigation.

Authors:  Ester Quilez; Richard K Burchell; Eric B Thorstensen; Karin Weidgraaf; Stacey E Parbhu; Nicolas Lopez-Villalobos; Arnon Gal
Journal:  J Vet Diagn Invest       Date:  2020-01-10       Impact factor: 1.279

5.  The epidemiology of cruciate ligament rupture in an insured Swedish dog population.

Authors:  Karolina Engdahl; Ulf Emanuelson; Odd Höglund; Annika Bergström; Jeanette Hanson
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

6.  Adrenal cortex stimulation with hCG in spayed female dogs with Cushing's syndrome: Is the LH-dependent variant possible?

Authors:  Ignacio M Espiñeira; Patricia N Vidal; María C Ghersevich; Elber A Soler Arias; Fernanda Bosetti; María F Cabrera Blatter; Diego D Miceli; Víctor A Castillo
Journal:  Open Vet J       Date:  2021-06-29

7.  Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.

Authors:  Su-Min Park; Kyeong-Bo Kim; Woo-Jin Song; Hwa-Young Youn
Journal:  Vet Med Sci       Date:  2021-03-23

8.  Patterns of the low-dose dexamethasone suppression test in canine hyperadrenocorticism revisited.

Authors:  Florian K Zeugswetter; Alejandra Carranza Valencia; Kerstin Glavassevich; Ilse Schwendenwein
Journal:  Vet Clin Pathol       Date:  2021-03-16       Impact factor: 1.180

9.  Validation study of canine serum cortisol measurement with the Immulite 2000 Xpi cortisol immunoassay.

Authors:  Jérémie Korchia; Kathleen P Freeman
Journal:  J Vet Diagn Invest       Date:  2021-07-22       Impact factor: 1.569

10.  Suspected spontaneous hyperadrenocorticism in a young experimental beagle dog.

Authors:  Ryo D Obara; Yuki Kato; Yoshiji Asaoka; Miho Mukai; Keigo Matsuyama; Kae Fujisawa; Minako Tajiri; Tamio Fukushima; Mikinori Torii
Journal:  J Toxicol Pathol       Date:  2021-03-01       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.